agitg trial news

AGITG Trial News

AGITG Trial news: The AGITG currently has fourteen studies open to recruitment and three studies in follow up.

The table below details the AGITG trials that are currently accruing patients.

Recruited Target Recruitment Period (months) Date of First Site Open (ANZ) Number of Sites Open 
ACTICCA-1 23 40 36 25 July 2016 13
ASCOLT 426 460 48 18 June 2014 32
ASCOLT – Global 1519 1587
DYNAMIC-III 379 1000 54 09 October 2017 40
DYNAMIC-Pancreas 37 438 54 01 March 2019 22
DYNAMIC-Rectal 156 408 36 18 June 2018 35
INTEGRATE II 71 90 48 19 October 2016 27
INTEGRATE II – Global 203 350 63
MASTERPLAN 1 120 48 01 October 2019 4
MONARCC 21 80 24 20 June 2018 22
NABNEC 40 58 54 15 September 2016 17
Neo-CREATE 8 20 36 17 June 2019 4
PALEO 2 54 36 16 September 2019 1
RENO 22 250 36 21 January 2019 3
SPAR 58 222 48 13 April 2018 15
TOP GEAR 237 280 118 29 September 2009 27
TOP GEAR – Global 544 570 41

Recruitment figures are for Australian and New Zealand sites as at end July 2020.

Trial Results Lay Summaries (click on the links below): 
Adjuvant GIST/ EORTC 62024
Advanced GIST
A La CaRT
ATTACHE
ATTAX-3
CO.17
CO.23
GAP
ICECREAM
INTEGRATE
MAX
PAN 1
REGISTER
SCOT
TACTIC
TOP GEAR
TROG 01.04 / IG0103R

Share